Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
CMS quietly offers unapproved hemp-derived cannabinoids to Medicare beneficiaries.
CMS is quietly offering unvalidated hemp-derived cannabinoid products, including those with delta-9 THC, to Medicare beneficiaries through pilot programs without FDA approval or physician prescriptions.
Critics warn this exposes elderly patients to uncontrolled risks, while the government argues statutory exemptions prevent judicial review and that congressional oversight is the proper check.
7 Articles
CMS ofrece silenciosamente cannabinoides no aprobados derivados del cáñamo a los beneficiarios de Medicare.